DE69833798D1 - Trialkyl-blockierung-vereinfachte polymerische medikamentenvorstufen von aminogruppen enthaltenden bioaktiven substanzen - Google Patents
Trialkyl-blockierung-vereinfachte polymerische medikamentenvorstufen von aminogruppen enthaltenden bioaktiven substanzenInfo
- Publication number
- DE69833798D1 DE69833798D1 DE69833798T DE69833798T DE69833798D1 DE 69833798 D1 DE69833798 D1 DE 69833798D1 DE 69833798 T DE69833798 T DE 69833798T DE 69833798 T DE69833798 T DE 69833798T DE 69833798 D1 DE69833798 D1 DE 69833798D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted
- aryls
- alkyls
- cycloalkyls
- polymeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polyamides (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyethers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/000,676 US5965119A (en) | 1997-12-30 | 1997-12-30 | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
US676 | 1997-12-30 | ||
US09/137,430 US6303569B1 (en) | 1997-12-30 | 1998-08-21 | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
US137430 | 1998-08-21 | ||
PCT/US1998/027805 WO1999033483A1 (en) | 1997-12-30 | 1998-12-29 | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69833798D1 true DE69833798D1 (de) | 2006-05-04 |
DE69833798T2 DE69833798T2 (de) | 2007-02-22 |
Family
ID=21692562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69833798T Expired - Lifetime DE69833798T2 (de) | 1997-12-30 | 1998-12-29 | Trialkyl-blockierung-vereinfachte polymerische medikamentenvorstufen von aminogruppen enthaltenden bioaktiven substanzen |
Country Status (10)
Country | Link |
---|---|
US (2) | US5965119A (de) |
EP (1) | EP1041995B1 (de) |
JP (2) | JP4728478B2 (de) |
AT (1) | ATE319469T1 (de) |
AU (1) | AU2021299A (de) |
CA (1) | CA2309954C (de) |
DE (1) | DE69833798T2 (de) |
DK (1) | DK1041995T3 (de) |
ES (1) | ES2260859T3 (de) |
WO (1) | WO1999033483A1 (de) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100361933B1 (ko) | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트 |
US6180095B1 (en) * | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
AU1825299A (en) | 1997-12-17 | 1999-07-05 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
US6624142B2 (en) | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
US5965119A (en) * | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
US6326507B1 (en) * | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
LT2599503T (lt) | 1998-10-16 | 2017-06-26 | Biogen Ma Inc. | Interferono beta-1a polimero konjugatai ir jų panaudojimas |
CN100480266C (zh) * | 1998-10-16 | 2009-04-22 | 拜奥根Idec马萨诸塞公司 | 干扰素-β融合蛋白及用途 |
EP1183230A1 (de) * | 1999-06-08 | 2002-03-06 | La Jolla Pharmaceutical | Valenz-plattformmoleküle mit aminooxygruppen |
WO2001017564A2 (en) * | 1999-09-10 | 2001-03-15 | The Procter & Gamble Company | Enzyme inhibitors |
US6713454B1 (en) * | 1999-09-13 | 2004-03-30 | Nobex Corporation | Prodrugs of etoposide and etoposide analogs |
US6376470B1 (en) * | 1999-09-23 | 2002-04-23 | Enzon, Inc. | Polymer conjugates of ara-C and ara-C derivatives |
BR0109266A (pt) * | 2000-03-15 | 2003-04-29 | Bristol Myers Squibb Pharma Co | Composto, composição farmacêutica, método de tratamento de um mamìfero afetado com um câncer, método de liberação de um composto nas células de um mamìfero afetado com um câncer e uso do composto |
WO2001093914A2 (en) | 2000-06-08 | 2001-12-13 | La Jolla Pharmaceutical Company | Multivalent platform molecules comprising high molecular weight polyethylene oxide |
AU2002218769A1 (en) * | 2000-07-12 | 2002-01-21 | Gryphon Therapeutics, Inc. | Chemokine receptor modulators, production and use |
US7118737B2 (en) * | 2000-09-08 | 2006-10-10 | Amylin Pharmaceuticals, Inc. | Polymer-modified synthetic proteins |
KR20030046411A (ko) * | 2000-09-08 | 2003-06-12 | 그리폰 테라퓨틱스, 인코포레이티드 | '위'-천연 화학적 라이게이션 |
US7435755B2 (en) * | 2000-11-28 | 2008-10-14 | The Trustees Of Dartmouth College | CDDO-compounds and combination therapies thereof |
JP2004530736A (ja) * | 2001-02-20 | 2004-10-07 | エンゾン ファーマシューティカルズ,インコーポレーテッド | 末端分枝高分子リンカーおよびそれを含む高分子複合体 |
EP1362053B1 (de) * | 2001-02-20 | 2007-11-14 | Enzon, Inc. | Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate |
GB0105929D0 (en) * | 2001-03-09 | 2001-04-25 | Btg Int Ltd | Physiologically activated prodrugs |
DE60233315D1 (de) | 2001-03-23 | 2009-09-24 | Enzon Inc | Prodrugs von krebsmitteln mit substituierten aromatischen säuren |
US20040077835A1 (en) * | 2001-07-12 | 2004-04-22 | Robin Offord | Chemokine receptor modulators, production and use |
EP1501352B1 (de) | 2001-12-14 | 2015-02-18 | The University Of Wyoming | Kontrollierte freisetzung von oxycodon |
EP1465615B1 (de) * | 2002-01-15 | 2012-08-01 | Trustees of Dartmouth College | Trizyklische bisenon-derivate und verfahren zu ihrer verwendung |
CN101700401B (zh) | 2002-01-18 | 2013-08-14 | 比奥根艾迪克Ma公司 | 具有用于共轭生物活性化合物的部分的聚亚烷基二醇 |
US8129330B2 (en) * | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
US20040062748A1 (en) * | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
US7265096B2 (en) * | 2002-11-04 | 2007-09-04 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
WO2004043396A2 (en) * | 2002-11-09 | 2004-05-27 | Nobex Corporation | Modified carbamate-containing prodrugs and methods of synthesizing same |
AU2003295433A1 (en) * | 2002-11-12 | 2004-06-03 | Enzon Pharmaceuticals, Inc. | Branched polymeric prodrugs of vancomycin |
WO2004044223A2 (en) * | 2002-11-12 | 2004-05-27 | Enzon Pharmaceuticals, Inc. | Prodrugs of vancomycin with hydrolysis resistant polymer linkers |
US7273845B2 (en) * | 2002-11-12 | 2007-09-25 | Enzon Pharmaceuticals, Inc. | Polymeric prodrugs of vancomycin |
AU2003303595A1 (en) | 2002-12-30 | 2004-07-29 | Gryphon Therapeutics, Inc. | Water-soluble thioester and selenoester compounds and methods for making and using the same |
ATE466953T1 (de) * | 2003-01-17 | 2010-05-15 | Advanced Proteome Therapeutics | Verfahren zur identifizierung aktivierter polymer-komplexe zur sekundären stellen-spezifischen modifikation von protein ziel-gruppen. |
NZ542687A (en) * | 2003-04-13 | 2010-02-26 | Enzon Pharmaceuticals Inc | Polymeric oligonucleotide prodrugs |
WO2005016312A1 (en) | 2003-08-13 | 2005-02-24 | Nobex Corporation | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
US7534902B2 (en) * | 2003-11-14 | 2009-05-19 | Wisconsin Alumni Research Foundation | Fluorescence assays with improved sensitivity |
EP1734988A4 (de) * | 2004-03-01 | 2009-08-05 | Enzon Pharmaceuticals Inc | Interferon-beta-polymerkonjugate |
ES2741524T3 (es) * | 2004-03-23 | 2020-02-11 | Ascendis Pharma Gmbh | Profármaco polimérico con un enlazador autoinmolador |
DE602005009255D1 (de) * | 2004-12-17 | 2008-10-02 | Lilly Co Eli | Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit |
US7365127B2 (en) * | 2005-02-04 | 2008-04-29 | Enzon Pharmaceuticals, Inc. | Process for the preparation of polymer conjugates |
EP2314320A2 (de) | 2005-04-05 | 2011-04-27 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Verfahren zur Abschirmung von funktionalen Stellen oder Epitopen von Proteinen |
JP5137814B2 (ja) * | 2005-04-06 | 2013-02-06 | ジェンザイム・コーポレーション | 治療ターゲティングのための酸不安定リンカーを介するpegおよびポリシアルリソソーム酵素のコンジュゲート |
US8133707B2 (en) * | 2006-01-17 | 2012-03-13 | Enzon Pharmaceuticals, Inc. | Methods of preparing activated polymers having alpha nitrogen groups |
US9603941B2 (en) * | 2006-01-24 | 2017-03-28 | Minghui Chai | Method of preparing dendritic drugs |
WO2007130453A2 (en) * | 2006-05-02 | 2007-11-15 | Allozyne, Inc. | Non-natural amino acid substituted polypeptides |
US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
CA2652256A1 (en) * | 2006-06-09 | 2007-12-21 | Enzon Pharmaceuticals, Inc. | Indenoisoquinoline-releasable polymer conjugates |
AU2007275535B2 (en) * | 2006-06-30 | 2012-08-16 | Servier IP UK Limited | Recombinant host for producing L-asparaginase II |
US8110559B2 (en) * | 2006-09-15 | 2012-02-07 | Enzon Pharmaceuticals, Inc. | Hindered ester-based biodegradable linkers for oligonucleotide delivery |
CA2662520A1 (en) * | 2006-09-15 | 2008-03-20 | Enzon Pharmaceuticals, Inc. | Polymeric conjugates containing positively-charged moieties |
AU2007296189A1 (en) * | 2006-09-15 | 2008-03-20 | Enzon Pharmaceuticals, Inc. | Polyalkylene oxides having hindered ester-based biodegradable linkers |
EP2073820A4 (de) * | 2006-09-15 | 2014-07-16 | Belrose Pharma Inc | Gezielte polymer-prodrugs mit multifunktionalen verknüpfern |
US8367065B2 (en) * | 2006-09-15 | 2013-02-05 | Enzon Pharmaceuticals, Inc. | Targeted polymeric prodrugs containing multifunctional linkers |
AU2007296054B2 (en) * | 2006-09-15 | 2013-03-28 | Enzon Pharmaceuticals, Inc. | Hindered ester-based biodegradable linkers for oligonucleotide delivery |
US7985783B2 (en) | 2006-09-21 | 2011-07-26 | The Regents Of The University Of California | Aldehyde tags, uses thereof in site-specific protein modification |
JP2010510243A (ja) * | 2006-11-17 | 2010-04-02 | トラスティーズ オブ ダートマス カレッジ | 三環系−ビス−エノン(tbe)の合成および生物学的活性 |
US8921340B2 (en) | 2006-11-17 | 2014-12-30 | Trustees Of Dartmouth College | Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions |
US8299046B2 (en) * | 2006-11-17 | 2012-10-30 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
US20100279408A1 (en) * | 2006-11-27 | 2010-11-04 | Enzon Pharmaceuticals, Inc. | Polymeric short interfering rna conjugates |
CA2671209A1 (en) * | 2006-12-29 | 2008-07-10 | Enzon Pharmaceuticals, Inc. | Use of adenosine deaminase for treating pulmonary disease |
US8071741B2 (en) * | 2007-04-20 | 2011-12-06 | Defiante Farmaceutica, S.A. | Stable recombinant adenosine deaminase |
NZ580980A (en) * | 2007-04-20 | 2012-04-27 | Sigma Tau Rare Diseases S A | Enzymatic anticancer therapy |
CA2693645A1 (en) * | 2007-07-11 | 2009-01-15 | Enzon Pharmaceuticals, Inc. | Polymeric drug delivery systems containing an aromatic allylic acid |
US20090016985A1 (en) * | 2007-07-11 | 2009-01-15 | Enzon Pharmaceuticals, Inc. | Polymeric drug delivery system containing a multi-substituted aromatic moiety |
WO2009023845A2 (en) * | 2007-08-15 | 2009-02-19 | The Board Of Regents Of The University Of Texas System | Combination therapy with synthetic triterpenoids and gemcitabine |
CA2707840A1 (en) * | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
WO2009042064A2 (en) | 2007-09-21 | 2009-04-02 | Nektar Therapeutics Al, Corporation | Oligomer-nucleoside phosphate conjugates |
BRPI0818004B8 (pt) | 2007-10-16 | 2021-05-25 | Biocon Ltd | composição farmacêutica sólida administrável por via oral e o processo da mesma. |
CA3062806C (en) * | 2008-01-11 | 2022-09-13 | Reata Pharmaceuticals, Inc. | Synthetic triterpenoids and methods of use in the treatment of disease |
TWI442925B (zh) | 2008-04-18 | 2014-07-01 | Reata Pharmaceuticals Inc | 抗氧化性發炎調節劑:c-環飽和之齊墩果酸衍生物 |
ES2703274T3 (es) | 2008-04-18 | 2019-03-07 | Reata Pharmaceuticals Inc | Moduladores de la inflamación antioxidantes: derivados del ácido oleanólico con modificaciones amino y otras en C-17 |
KR101782020B1 (ko) * | 2008-04-18 | 2017-09-26 | 리타 파마슈티컬스 잉크. | 산화방지성 염증 조절제 c-17 일치된 올레아놀산 유도체 |
CA2721665C (en) | 2008-04-18 | 2017-01-24 | Reata Pharmaceuticals, Inc. | Compounds including an anti-inflammatory pharmacore and methods of use |
TW201004627A (en) * | 2008-04-18 | 2010-02-01 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
AU2009274037B2 (en) | 2008-07-22 | 2015-07-09 | Trustees Of Dartmouth College | Monocyclic cyanoenones and methods of use thereof |
EP2717699B1 (de) * | 2011-06-06 | 2020-06-03 | Veiled Therapeutics LLC | Säurelabile lipophile Prodrugs chemotherapeutischer Antikrebsmittel |
DE102011118029A1 (de) | 2011-06-20 | 2012-12-20 | Universität Leipzig | Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung |
HUE029855T2 (en) | 2011-07-05 | 2017-04-28 | Bioasis Technologies Inc | p97 antibody conjugates |
CN108686203A (zh) | 2012-04-04 | 2018-10-23 | 哈洛齐梅公司 | 使用抗透明质酸剂和肿瘤靶向紫杉烷的组合疗法 |
US8921419B2 (en) | 2012-05-08 | 2014-12-30 | Trustees Of Dartmouth College | Triterpenoids and compositions containing the same |
CA2880162C (en) | 2012-07-31 | 2023-04-04 | Bioasis Technologies, Inc. | Dephosphorylated lysosomal storage disease proteins and methods of use thereof |
WO2014074218A1 (en) | 2012-11-12 | 2014-05-15 | Redwood Bioscience, Inc. | Compounds and methods for producing a conjugate |
CA2890906A1 (en) | 2012-11-16 | 2014-05-22 | The Regents Of The University Of California | Pictet-spengler ligation for protein chemical modification |
US9310374B2 (en) | 2012-11-16 | 2016-04-12 | Redwood Bioscience, Inc. | Hydrazinyl-indole compounds and methods for producing a conjugate |
WO2014160438A1 (en) | 2013-03-13 | 2014-10-02 | Bioasis Technologies Inc. | Fragments of p97 and uses thereof |
AU2014312190A1 (en) | 2013-08-28 | 2016-02-18 | Bioasis Technologies Inc. | CNS-targeted conjugates of antibodies |
PT3057585T (pt) | 2013-10-15 | 2020-10-21 | Seagen Inc | Fármaco-ligadores peguilados para farmacocinética melhorada de conjugados de fármaco-ligando |
WO2015081282A1 (en) | 2013-11-27 | 2015-06-04 | Redwood Bioscience, Inc. | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate |
AU2015222879B2 (en) | 2014-02-26 | 2019-12-05 | The Board Of Regents Of The University Of Texas System | Nitrobenzaldehyde proton release for manipulation of cellular acidosis |
PL3207130T3 (pl) | 2014-10-14 | 2020-02-28 | Halozyme, Inc. | Kompozycje deaminazy adenozyny 2 (ada2), jej warianty i sposoby ich zastosowania |
US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
MX2018006218A (es) | 2015-12-04 | 2018-09-05 | Seattle Genetics Inc | Conjugados de compuestos de tubulisina cuaternizada. |
BR112018069273A2 (pt) | 2016-03-25 | 2019-01-22 | Seattle Genetics Inc | métodos para preparação de um composto e para tratamento de um indivíduo com uma malignidade hematológica, composto, composição, e, intermediário ligante de fármaco ou composto ligante de fármaco |
KR20220150408A (ko) | 2016-11-14 | 2022-11-10 | 항저우 디에이씨 바이오테크 씨오, 엘티디 | 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용 |
MX2019010769A (es) | 2017-03-24 | 2019-12-11 | Seattle Genetics Inc | Proceso para la preparacion de enlazadores de farmacos de glucuronidos y compuestos intermediarios de los mismos. |
JP7338873B2 (ja) | 2017-07-19 | 2023-09-05 | ユニケリス・リミテッド | 強皮症関連血管障害を治療または改善するための組成物および方法 |
EP3732254A4 (de) | 2017-12-26 | 2021-12-22 | Becton, Dickinson and Company | Tiefe uv-erregbare wassersolvatisierte polymerfarbstoffe |
WO2019191482A1 (en) | 2018-03-30 | 2019-10-03 | Becton, Dickinson And Company | Water-soluble polymeric dyes having pendant chromophores |
US20190351031A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
EP3813867A1 (de) | 2018-07-22 | 2021-05-05 | Bioasis Technologies Inc. | Behandlung von lymphatischen metastasen |
US20210355468A1 (en) | 2020-05-18 | 2021-11-18 | Bioasis Technologies, Inc. | Compositions and methods for treating lewy body dementia |
US20210393787A1 (en) | 2020-06-17 | 2021-12-23 | Bioasis Technologies, Inc. | Compositions and methods for treating frontotemporal dementia |
CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
CN112707947B (zh) * | 2020-12-29 | 2022-06-17 | 湖南华腾制药有限公司 | 一种阿霉素前药及其制备方法与应用 |
EP4155349A1 (de) | 2021-09-24 | 2023-03-29 | Becton, Dickinson and Company | Wasserlösliche gelbe grünabsorbierende farbstoffe |
WO2024007016A2 (en) | 2022-07-01 | 2024-01-04 | Beckman Coulter, Inc. | Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives |
WO2024044327A1 (en) | 2022-08-26 | 2024-02-29 | Beckman Coulter, Inc. | Dhnt monomers and polymer dyes with modified photophysical properties |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
JP2958019B2 (ja) * | 1988-05-06 | 1999-10-06 | 住友製薬株式会社 | ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法 |
US5112739A (en) * | 1988-08-02 | 1992-05-12 | Polaroid Corporation | Enzyme controlled release system |
US5122614A (en) * | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5130126A (en) * | 1990-07-09 | 1992-07-14 | Nippon Oil & Fats Co., Ltd. | Polymer-drug conjugate and a method of producing it |
FR2676058B1 (fr) * | 1991-04-30 | 1994-02-25 | Hoechst Lab | Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers. |
US5349001A (en) * | 1993-01-19 | 1994-09-20 | Enzon, Inc. | Cyclic imide thione activated polyalkylene oxides |
US5321095A (en) * | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5605976A (en) * | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
US5643575A (en) * | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5672584A (en) * | 1995-04-25 | 1997-09-30 | The University Of Kansas | Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability |
PT751144E (pt) * | 1995-06-27 | 2004-12-31 | Pharmachemie Bv | Novos pro-farmacos antraciclinicos, metodo para preparacao e tambem a sua utilizacao em quimioterapia selectiva |
CA2264227A1 (en) | 1996-09-27 | 1998-04-02 | Raymond A. Firestone | Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
US5965119A (en) * | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
-
1997
- 1997-12-30 US US09/000,676 patent/US5965119A/en not_active Expired - Lifetime
-
1998
- 1998-08-21 US US09/137,430 patent/US6303569B1/en not_active Expired - Fee Related
- 1998-12-29 ES ES98965013T patent/ES2260859T3/es not_active Expired - Lifetime
- 1998-12-29 DK DK98965013T patent/DK1041995T3/da active
- 1998-12-29 CA CA2309954A patent/CA2309954C/en not_active Expired - Fee Related
- 1998-12-29 AU AU20212/99A patent/AU2021299A/en not_active Abandoned
- 1998-12-29 JP JP2000526236A patent/JP4728478B2/ja not_active Expired - Fee Related
- 1998-12-29 AT AT98965013T patent/ATE319469T1/de not_active IP Right Cessation
- 1998-12-29 DE DE69833798T patent/DE69833798T2/de not_active Expired - Lifetime
- 1998-12-29 EP EP98965013A patent/EP1041995B1/de not_active Expired - Lifetime
- 1998-12-29 WO PCT/US1998/027805 patent/WO1999033483A1/en active IP Right Grant
-
2010
- 2010-06-23 JP JP2010142924A patent/JP2010235624A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2309954C (en) | 2011-12-06 |
WO1999033483A1 (en) | 1999-07-08 |
AU2021299A (en) | 1999-07-19 |
EP1041995A4 (de) | 2004-10-06 |
DK1041995T3 (da) | 2006-07-10 |
ES2260859T3 (es) | 2006-11-01 |
ATE319469T1 (de) | 2006-03-15 |
DE69833798T2 (de) | 2007-02-22 |
JP2010235624A (ja) | 2010-10-21 |
JP4728478B2 (ja) | 2011-07-20 |
EP1041995B1 (de) | 2006-03-08 |
EP1041995A1 (de) | 2000-10-11 |
US6303569B1 (en) | 2001-10-16 |
JP2001527049A (ja) | 2001-12-25 |
US5965119A (en) | 1999-10-12 |
CA2309954A1 (en) | 1999-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69833798D1 (de) | Trialkyl-blockierung-vereinfachte polymerische medikamentenvorstufen von aminogruppen enthaltenden bioaktiven substanzen | |
HUP0400655A2 (hu) | Zárványkomplexeket tartalmazó készítmények és eljárás az előállításukra | |
DE69841206D1 (de) | Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien | |
DK0521787T3 (da) | Vanadiumkomplekser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
TW354807B (en) | Antifouling coating composition | |
NO912672D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer. | |
KR920005968A (ko) | 모발 처리 조성물 | |
CA2312975A1 (en) | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents | |
BR9811874A (pt) | Composições detergentes para lavanderia com polìmeros baseados em aminoácido para proporcionar benefìcios de aparência e integridade aos tecidos lavados com as mesmas | |
KR950017976A (ko) | 폴리아미노화 리간드와 이의 금속착염 | |
AR009127A1 (es) | Procedimiento de preparacion de nanoparticulas de metilideno malona, particulas que contienen eventualmente una o mas moleculas biologicamente activas y composiciones farmaceuticas que las contienen | |
ES2162483T3 (es) | Utilizacion de polimeros hiperramificados y de dendrimeros que comprenden un grupo particular, como agente formador de pelicula, las composiciones filmogenas que los incluyen y su utilizacion particularmente en cosmetica o en farmacia. | |
AR247906A1 (es) | Composicion polimerica entrecruzable para preparar formulaciones curables de recubrimiento y pintura. | |
CO4920202A1 (es) | Composicion de champu acondicionar que contiene polimeros polimerizados en emulsion y metodo para su preparacion | |
ES2160253T3 (es) | Agentes de enjuagado-aclarado con polimeros cationicos. | |
DE69326231T2 (de) | Cholesterinspiegelsenkendes mittel | |
HUP0002404A2 (hu) | Aminosavszármazékok, hatóanyagként ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk | |
BR9802585A (pt) | Composição cosméticas e/ou dermatológica, processo de maquilagem e processo de tratamento cosméticos. | |
DE69917281D1 (de) | Coumarin und damit verwandte aromatische polymere prodrugs | |
ES2126673T3 (es) | Iniciadores de polimerizacion anionica solubilizados y productos de los mismos. | |
DE69312984T2 (de) | Substituierte Aminophosphonatderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
DE69203551T2 (de) | Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung. | |
GB1192603A (en) | Organophosphines and Organophosphine Compositions having Keratin-Deforming Properties | |
DE68906572D1 (de) | Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE258782T1 (de) | Mittel und verfahren zur färbung von fasern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |